Biotech

All Articles

Praxis epilepsy medication lowers seizures in phase 2 trial

.Practice Accuracy Medicines has scored yet another midphase win in epilepsy this year, along with i...

Three officers surrender as Dyne blog posts mixed records for DMD prospect

.After getting away from a medical hold a number of years back, Dyne Therapeutics has disclosed new ...

Arrowhead fires off period 3 records in uncommon metabolic illness ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has actually shown its hand in front of a possible face-off with Ionis, r...

Pfizer, Valneva present lyme condition chance reliable for 2nd booster

.Pfizer and Valneva might have concerning pair of more years to hang around before they help make th...

Fierce Biotech Managing Editor Ayla Ellison Speaks Patronize Michelle Benz on the Future of Biotech.

.Let's dive into a conversation with Ayla Ellison, Brutal Biotech Managing Editor and Michelle Benz ...

New records demonstrate how Bayer's asundexian stopped working to avoid strokes

.Bayer suspended the phase 3 test for its own variable XIa prevention asundexian late in 2014 after ...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is still set on taking its own several sclerosis (MS) med tolebrutinib to the FDA, execs hav...

Galapagos' stockpile as fund shows intent to mold its own evolution

.Galapagos is actually happening under extra stress from capitalists. Having constructed a 9.9% conc...

Cell- focused Sana gathers very first CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of considerable management hirings, shootings an...

Allist pays Jacobio $21M, landing task in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has gotten on its own a starring role in China's KRAS market, payin...